| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |